STAAR Surgical Company
STAA
Rank in Stocks
#7800
STAAR Surgical Company, along with its subsidiaries, specializes in... STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.
Share Price
$24.55
Last synced: 2026-11-09
Market Cap
$1.23B
Change (1 day)
-2.62%
Change (1 year)
-10.40%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade STAAR Surgical Company (STAA)
Category
Healthcare
EPS for STAAR Surgical Company (STAA)
EPS as of October 2026 TTM: $0.01
According to STAAR Surgical Company's latest financial reports, its current EPS (TTM) is $0.01. At the end of 2024 the company had an EPS of $-0.41, a decrease compared to its 2023 EPS of $0.44.
EPS history for STAAR Surgical Company from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.01 | -102.44% |
| 2024 | $-0.41 | -193.18% |
| 2023 | $0.44 | -46.99% |
| 2022 | $0.83 | 59.62% |
| 2021 | $0.52 | 62.50% |
| 2020 | $0.32 | 190.91% |
| 2018 | $0.11 | -310.73% |
| 2017 | $-0.05 | -82.60% |
| 2016 | $-0.30 | 36.36% |
| 2015 | $-0.22 | -2,300.00% |
| 2014 | $0.01 | -120.00% |
| 2012 | $-0.05 | -225.00% |
| 2011 | $0.04 | 2,566.67% |
| 2010 | 0.00 | -100.19% |
| 2009 | $-0.79 | 38.60% |
| 2007 | $-0.57 | -5.00% |
| 2006 | $-0.60 | 27.66% |
| 2005 | $-0.47 | -18.97% |
| 2004 | $-0.58 | -42.00% |
| 2003 | $-1.00 | 14.94% |
| 2001 | $-0.87 | -29.27% |
| 2000 | $-1.23 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.37 | 83,600.00% |
US
|
|
| $6.02 | 60,119.00% |
FR
|
|
| $4.15 | 41,400.00% |
US
|
|
| $5.32 | 53,101.00% |
JP
|
|
| $1.29 | 12,800.00% |
CH
|
Questions about STAAR Surgical Company's earnings per share (EPS)
What is STAAR Surgical Company's earnings per share (EPS)?
STAAR Surgical Company's earnings per share (EPS) over the last twelve months is $0.01, as of Oct 2026.
What was STAAR Surgical Company's earnings per share (EPS) in 2024?
In 2024, STAAR Surgical Company's earnings per share (EPS) was $-0.41, compared with $0.44 in 2023.
How has STAAR Surgical Company's earnings per share (EPS) changed since 2020?
From 2020 to 2024, STAAR Surgical Company's earnings per share (EPS) was highest in 2022 ($0.83) and lowest in 2024 ($-0.41).
How does STAAR Surgical Company's earnings per share (EPS) compare with similar companies?
STAAR Surgical Company's earnings per share (EPS) ($0.01) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.